References
- D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Quart J Med. 1987;64(245):709–727
- Galla JH. IgA Nephropathy. Kidney Int. 1995;47(2):377–387
- Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738–748
- Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368:2402–2414
- Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol. 2005;16:2088–2097
- Li PK, Ho KK, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese – Clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17:64–69
- Moriyama T, Tanaka K, Iwasaki C, et al. Prognosis in IgA nephropathy: 30-Year analysis of 1012 patients at a single center in Japan. PLoS One. 2014;9(3):e91756
- Xie J, Kiryluk K, Wang W, et al. Predicting progression of IgA nephropathy: New clinical progression risk score. PLoS One. 2012;7(6):e38904
- Lundberg S, Qureshi AR, Olivecrona S, et al. FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy. Clin J Am Soc Nephrol. 2012;7(5):727–734
- Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724–1734
- Espinosa M, Ortega R, Gómez-Carrasco JM, et al. Mesangial C4d deposition: A new prognostic factor in IgA nephropathy. Nephrol Dial Transplant. 2009;24:886–891
- Espinosa M, Ortega R, Sanchez M, et al. Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2014;9(5):897–904
- Sahin OZ, Yavas H, Taslı F, et al. Prognostic value of glomerular C4d staining in patients with IgA nephritis. Int J Clin Exp Pathol. 2014;7(6):3299–3304
- Nasri H, Ahmadi A, Rafieian-Kopaei M, Bashardoust B, Nasri P Mubarak M. Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients; a preliminary study. J Nephropathol. 2015;4(1):19–23
- Faria B, Henriques C, Matos AC, Daha MR, Pestana M, Seelen M. Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression. Clin Exp Immunol. 2015;179(2):354–361
- Roberts ISD. Pathology of IgA nephropathy. Nat Rev Nephrol. 2014;10:445–454
- Kitching AR, Holdsworth SR, Tipping PG. IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol. 1999;10:752–759
- McMullen ME, Hart ML, Walsh MC, Buras J, Takahashi K, Stahl GL. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology. 2006;211:759–766
- Kiryluk K, Li Y, Sanna-Cherchi S, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8(6):e1002765
- Suzuki T, Horita S, Kadoya K, et al. C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clin Exp Nephrol. 2007;11(4):287–291